The inability of late stage–disease microglia to control plaque load with AD progression may be attributed to the reduced expression of Aβ binding receptors and Aβ-degrading enzymes as plaque deposition increases with age, and this was shown to lead to decreased phagocytosis and degradation of amyloid material in APP/PS1 mice (50). This evidence concerns the gene APP and Alzheimer disease.